You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 259 No. 1, January 1, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Oral Contraceptives and Cervical Cancer Risk in Costa Rica

Detection Bias or Causal Association?

Kathleen L. Irwin, MD; Luis Rosero-Bixby; Mark W. Oberle, MD; Nancy C. Lee, MD; Anne S. Whatley, MS; Judith A. Fortney, PhD; Michele G. Bonhomme, MSPH

JAMA. 1988;259(1):59-64.


Abstract

To examine the relationship between cervical cancer and oral contraceptive (OC) use, we analyzed data from a population-based, case-control study in Costa Rica. Women aged 25 to 58 years in whom cervical cancer was diagnosed and reported to the National Tumor Registry were examined as two separate case groups: invasive cervical cancer and carcinoma in situ (CIS). Controls were women aged 25 to 58 years identified through a national survey. Women who had used OCs had no increased risk of invasive cervical cancer compared with women who had never used OCs (relative risk, 0.8; 95% confidence interval, 0.5 to 1.3). Women who had used OCs had an increased risk of CIS compared with those who had never used OCs (relative risk, 1.6; 95% confidence interval, 1.2 to 2.2). However, further analyses indicated that this increased risk was confined to those who had recently used OCs. Also, the risk of CIS was not elevated in subgroups in which a history of cervical smears was not strongly linked to OC use. The elevated risk of CIS among OC users may therefore reflect a bias caused by enhanced detection of disease rather than a causal association.

(JAMA 1988;259:59-64)



Author Affiliations

From the Division of Reproductive Health, the Centers for Disease Control, Atlanta (Drs Irwin, Oberle, and Lee and Ms Whatley); Instituto de Investigaciones en Salud, University of Costa Rica, San José (Mr Rosero-Bixby); and Family Health International, Research Triangle Park, NC (Dr Fortney and Ms Bonhomme).


Footnotes

The opinions expressed in this article are the authors' and do not necessarily reflect the views of the US Agency for International Development.

Reprint requests to Division of Reproductive Health, Centers for Disease Control, Atlanta, GA 30333 (Dr Irwin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies
International Collaboration of Epidemiological Stu
Cancer Epidemiol. Biomarkers Prev. 2009;18:1060-1069.
ABSTRACT | FULL TEXT  

Risks for Incident Human Papillomavirus Infection and Low-Grade Squamous Intraepithelial Lesion Development in Young Females
Moscicki et al.
JAMA 2001;285:2995-3002.
ABSTRACT | FULL TEXT  

Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women
Schiff et al.
Int J Epidemiol 2000;29:983-990.
ABSTRACT | FULL TEXT  

Oral Contraceptives as Risk Factors for Cervical Adenocarcinomas and Squamous Cell Carcinomas
Lacey et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:1079-1085.
ABSTRACT | FULL TEXT  

Folate Deficiency and Cervical Dysplasia
Butterworth et al.
JAMA 1992;267:528-533.
ABSTRACT  

Oral Contraceptives and Cervical Cancer
Celentano
JAMA 1988;259:2696-2696.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.